StockTipsArenaBeta

BUY Fortis Healthcare — Mehul Kothari, Anand Rathi

BUYFortis Healthcare
Fortis Healthcare share price target & all analyst calls

byMehul Kothari, Anand RathiHorizon: NA (inferred Swing (≤2wk))13 Jul 2026via Zee Business (Live)

Entry₹961.85Inferred
Target₹1,000
Total upside +3.97% (call closed)
Stop loss₹938-2.48% risk
Exit₹93824 Jul 2026, 9:50 am
Stop-loss hit-2.48%
Follow Mehul Kothari for new calls(22% target hit, 99 closed calls)Get alertsWatch FORTIS for new buy/sell callsGet alertsSee 1 active Swing call on FORTISSee 152 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Jul 2026
5 supporting2 neutral0 opposing
Supports the BUY call (5)

Dr. Ashutosh Raghuvanshi has been appointed as the Managing Director & CEO of Fortis Healthcare Limited, effective March 19, 2027.

NSE · Appointment·8 Jul · 2w ago

(opens in new tab)

Fortis Healthcare's Board recommended the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and CEO for two years, effective March 19, 2027. He is not debarred from capital markets.

BSE · Company Update·8 Jul · 2w ago

(opens in new tab)

Fortis Healthcare Limited's board meeting confirmed the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director and Chief Executive Officer.

NSE · Outcome of Board Meeting·8 Jul · 2w ago

(opens in new tab)

Fortis Healthcare is entering Odisha by signing an Operations & Maintenance agreement with Dion Group for a new 300-bed multi-specialty hospital in Cuttack.

NSE · Press Release·3 Jul · 3w ago

(opens in new tab)

Fortis Healthcare has signed an O&M agreement with Dion Group for a 300-bed multi-specialty hospital in Cuttack, Odisha. This marks Fortis' entry into Odisha and is part of its expansion strategy.

BSE · Company Update·3 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Agilus Diagnostics Limited, a subsidiary of Fortis Healthcare Ltd, has appointed Vijender Singh as its Managing Director and Chief Executive Officer.

BSE · Company Update·20 Jul · 4d ago

(opens in new tab)

Fortis Healthcare Limited has set July 24, 2026, as the record date for dividend purposes.

NSE · Record Date·17 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Fortis Healthcare

All analyst calls on Fortis Healthcare

More from Mehul Kothari, Anand Rathi

Every call and its outcome